"Our study found the ratio of efficacy to side effects of the VNUS ClosureFAST catheter to be superior to any previous endovenous ablation device," said Dr. Proebstle. "In 223 cases where the ...

SAN JOSE, Calif., Aug. 14 VNUS(R) MedicalTechnologies, Inc. (Nasdaq: VNUS), a worldwide leader in medical devices forthe minimally invasive treatment of venous reflux disease, is enjoying ...

September 26, 2006 -- The US Food and Drug Administration (FDA) has granted a clinical laboratory improvement amendment waiver for a portable lead test, thereby improving its availability and access, ...

May 19, 2010 — Radiofrequency ablation (RFA) using ClosureFAST (VNUS) is similarly effective to laser for varicose veins but causes less postprocedural pain, according to the results of a randomized ...

Co announces the recent launch of the VNUS ClosureFAST catheter, a major advance in the treatment of the underlying cause of varicose veins. ClosureFAST is an endovenous radiofrequency ablation ...

DUBLIN - Feb. 10, 2015 - The ClosureFast(TM) endovenous radiofrequency ablation catheter from Medtronic plc (MDT) is safe and effective for the treatment of chronic venous insufficiency (CVI) over ...

Patients who received radiofrequency ablation for varicose veins reported less post-procedural pain than those treated with endovenous laser ablation. However, both groups reported the same clinical ...

SAN JOSE, Calif., Aug. 4 (UPI) -- VNUS Medical said Friday it has been cleared for U.S. sales of its ClosureFAST Catheter to treat peripheral vascular disease. The company said the product is a ...

Founded in 1995 and headquartered in San Jose, California, VNUS Medical Technologies is a worldwide leader in medical devices for the minimally invasive treatment of venous reflux disease, a ...

SAN JOSE, Calif., June 3 VNUS(R) MedicalTechnologies, Inc. (Nasdaq: VNUS) today announced that it has entered into anAgreement with AngioDynamics (Nasdaq: ANGO) and Vascular Solutions(Nasdaq: VASC) ...